Biogen Announces Webcast of Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference.Business Editors/Health/Medical Writers CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 3, 2003 Biogen, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BGEN BGen abbr. brigadier general ) announced today that its presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference will be webcast live on February 4, 2003. The live webcast begins at 11:05 am (EST EST electroshock therapy. EST abbr. electroshock therapy ) and is accessible through Biogen's homepage, www.Biogen.com. About Biogen Biogen is the world's oldest independent biotechnology company and a leader in biologics research, development and manufacturing. A pioneer in leading edge research in immunology, neurobiology Neurobiology Study of the development and function of the nervous system, with emphasis on how nerve cells generate and control behavior. The major goal of neurobiology is to explain at the molecular level how nerve cells differentiate and develop their and oncology, Biogen brings novel therapies to improve patients' lives around the world through its global marketing capabilities. For press releases and additional information about the company, please visit http://www.biogen.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion